Table 2.
Prevalence of patients treated with anti-diabetic medicine, excluding insulin and insulin analogues for all age groups and metformin for women less than 45 years old, in Greenland and Denmark.
| Males, % (95 %-CI) (n/N) |
Females, % (95 %-CI) (n/N) |
Total, % (95 %-CI) (n/N) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Age, years | GRL | DK | p (z-score) | GRL | DK | p (z-score) | GRL | DK | p(z-score) |
| 20–44 | 0.2 (0.1–0.3) (16/7,793) |
0.7 (0.6–0.7) (6,142/920,000) |
<0.001 (−5.00) |
0.2 (0.1–0.4) (16/7,248) |
0.1 (0.1–0.1) (884/895,845) |
0.001 (3.28) |
0.2 (0.1–0.3) (32/15,041) |
0.4 (0.4–0.4) (7,026/1,815,845) |
<0.001 (−3.43) |
| 45–49 | 1.1 (0.6–1.7) (18/1,677) |
3.1 (3.0–3.1) (6,251/203,825) |
<0.001 (−4.73) |
0.9 (0.5–1.5) (13/1,438) |
2.3 (2.2–2.3) (4,538/199,814) |
<0.001 (−3.47) |
1.0 (0.7–1.4) (31/3,115) |
2.7 (2.6–2.7) (10,789/403,639) |
<0.001 (−5.80) |
| 50–54 | 2.6 (1.9–3.3) (54/2,106) |
5.1 (5.0–5.2) (10,393/204,442) |
<0.001 (−5.25) |
2.1 (1.5–2.8) (38/1,833) |
3.5 (3.5–3.6) (7,119/201,332) |
<0.001 (−3.38) |
2.3 (1.9–2.9) (92/3,939) |
4.3 (4.3–4.4) (17,512/405,774) |
<0.001 (−6.10) |
| 55–59 | 3.5 (2.7–4.4) (61/1,754) |
7.4 (7.2–7.5) (13,240/179,791) |
<0.001 (−6.22) |
3.0 (2.2–4.1) (43/1,422) |
4.8 (4.7–4.9) (8,642/179,683) |
0.002 (−3.14) |
3.3 (2.7–4.0) (104/3,176) |
6.1 (6.0–6.2) (21,882/359,474) |
<0.001 (−6.61) |
| 60–64 | 6.1 (4.8–7.5) (74/1,223) |
9.8 (9.6–9.9) (16,295/166,766) |
<0.001 (−4.37) |
5.1 (3.8–6.7) (50/975) |
6.2 (6.0–6.3) (10,490/170,093) |
0.177 (−1.35) |
5.6 (4.7–6.7) (124/2,198) |
8.0 (7.9–8.0) (26,785/336,859) |
<0.001 (−3.99) |
| 65–69 | 8.4 (6.6–10.5) (69/819) |
12.0 (11.7–12.1) (20,079/168,573) |
0.002 (−3.07) |
8.5 (6.4–11.0) (52/612) |
7.5 (7.4–7.6) (13,191/175,775) |
0.352 (0.93) |
8.4 (7.0–10.0) (121/1,431) |
9.7 (9.6–9.8) (33,270/344,348) |
0.124 (−1.54) |
| 70–74 | 10.2 (8.0–13.0) (60/583) |
14.0 (13.8–14.2) (19,638/140,598) |
0.010 (−2.56) |
10.5 (8.0–13.7) (50/474) |
9.0 (8.8–9.1) (13,599/151,845) |
0.226 (1.21) |
10.4 (8.6–12.4) (110/1,057) |
11.3 (11.3–11.5) (33,237/292,443) |
0.327 (−0.98) |
| 75–79 | 13.1 (9.5–17.6) (38/289) |
14.0 (13.8–14.2) (12,456/89,001) |
0.682 (−0.41) |
12.8 (9.1–17.2) (36/282) |
9.9 (9.7–10.1) (10,379/104,872) |
0.107 (1.61) |
13.0 (10.3–16.0) (74/571) |
11.8 (11.6–11.9) (22,835/193,873) |
0.384 (0.87) |
| Total | 2.4 (2.1–2.6) (390/16,244) |
5.0 (5.0–5.0) (104,494/2,072,996) |
<0.001 (−15.35) |
2.1 (1.9–2.4) (305/14,284) |
3.7 (3.7–3.7) (77,033/2,079,259) |
<0.001 (−9.91) |
2.3 (2.1–2.5) (695/30,528) |
4.4 (4.4–4.4) (181,527/4,152,255) |
<0.001 (−34.68) |